Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

The dynamics of cortical and hippocampal atrophy in Alzheimer disease.

Sabuncu MR, Desikan RS, Sepulcre J, Yeo BT, Liu H, Schmansky NJ, Reuter M, Weiner MW, Buckner RL, Sperling RA, Fischl B; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Aug;68(8):1040-8. doi: 10.1001/archneurol.2011.167.

2.

Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum.

Donovan NJ, Wadsworth LP, Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Marshall GA; Alzheimer Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2014 Nov;22(11):1168-79. doi: 10.1016/j.jagp.2013.03.006. Epub 2013 Jul 24.

3.

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.

Portelius E, Zetterberg H, Skillbäck T, Törnqvist U, Andreasson U, Trojanowski JQ, Weiner MW, Shaw LM, Mattsson N, Blennow K; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2015 Nov;138(Pt 11):3373-85. doi: 10.1093/brain/awv267. Epub 2015 Sep 15.

4.

Topography of cortical thinning areas associated with hippocampal atrophy (HA) in patients with Alzheimer's disease (AD).

Kim GH, Jeon S, Seo SW, Kim MJ, Kim JH, Roh JH, Shin JS, Kim CH, Im K, Lee JM, Qiu A, Kim ST, Na DL.

Arch Gerontol Geriatr. 2012 Mar-Apr;54(2):e122-9. doi: 10.1016/j.archger.2011.10.013. Epub 2011 Nov 15.

PMID:
22088936
5.

The cortical signature of prodromal AD: regional thinning predicts mild AD dementia.

Bakkour A, Morris JC, Dickerson BC.

Neurology. 2009 Mar 24;72(12):1048-55. doi: 10.1212/01.wnl.0000340981.97664.2f. Epub 2008 Dec 24.

6.

Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease.

Teipel SJ, Grothe M, Lista S, Toschi N, Garaci FG, Hampel H.

Med Clin North Am. 2013 May;97(3):399-424. doi: 10.1016/j.mcna.2012.12.013. Epub 2013 Feb 1. Review.

PMID:
23642578
7.

Progressive cortical thinning and subcortical atrophy in dementia with Lewy bodies and Alzheimer's disease.

Mak E, Su L, Williams GB, Watson R, Firbank MJ, Blamire AM, O'Brien JT.

Neurobiol Aging. 2015 Apr;36(4):1743-1750. doi: 10.1016/j.neurobiolaging.2014.12.038. Epub 2015 Jan 8.

PMID:
25649023
8.

Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.

Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM.

Arch Neurol. 2006 May;63(5):693-9. Erratum in: Arch Neurol. 2007 Sep;64(9):1360-1.

PMID:
16682538
9.

Improved prediction of Alzheimer's disease with longitudinal white matter/gray matter contrast changes.

Grydeland H, Westlye LT, Walhovd KB, Fjell AM.

Hum Brain Mapp. 2013 Nov;34(11):2775-85. doi: 10.1002/hbm.22103. Epub 2012 Jun 5.

PMID:
22674625
10.

A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.

den Heijer T, van der Lijn F, Koudstaal PJ, Hofman A, van der Lugt A, Krestin GP, Niessen WJ, Breteler MM.

Brain. 2010 Apr;133(Pt 4):1163-72. doi: 10.1093/brain/awq048.

PMID:
20375138
11.

Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study.

Kim YJ, Cho H, Kim YJ, Ki CS, Chung SJ, Ye BS, Kim HJ, Kim JH, Kim ST, Lee KH, Jeon S, Lee JM, Chin J, Kim JH, Na DL, Seong JK, Seo SW.

J Alzheimers Dis. 2015;44(4):1075-85. doi: 10.3233/JAD-141773.

PMID:
25391384
12.

Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.

Doré V, Villemagne VL, Bourgeat P, Fripp J, Acosta O, Chetélat G, Zhou L, Martins R, Ellis KA, Masters CL, Ames D, Salvado O, Rowe CC.

JAMA Neurol. 2013 Jul;70(7):903-11. doi: 10.1001/jamaneurol.2013.1062.

PMID:
23712469
13.

Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, Stern Y, Tabert MH, de Leon MJ.

Neurology. 2007 Mar 13;68(11):828-36.

PMID:
17353470
14.

Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.

Henneman WJ, Sluimer JD, Barnes J, van der Flier WM, Sluimer IC, Fox NC, Scheltens P, Vrenken H, Barkhof F.

Neurology. 2009 Mar 17;72(11):999-1007. doi: 10.1212/01.wnl.0000344568.09360.31.

15.

Heterogeneity of Regional Brain Atrophy Patterns Associated with Distinct Progression Rates in Alzheimer's Disease.

Byun MS, Kim SE, Park J, Yi D, Choe YM, Sohn BK, Choi HJ, Baek H, Han JY, Woo JI, Lee DY; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2015 Nov 30;10(11):e0142756. doi: 10.1371/journal.pone.0142756. eCollection 2015.

16.

Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease.

Mungas D, Reed BR, Jagust WJ, DeCarli C, Mack WJ, Kramer JH, Weiner MW, Schuff N, Chui HC.

Neurology. 2002 Sep 24;59(6):867-73.

17.

Hippocampal degeneration is associated with temporal and limbic gray matter/white matter tissue contrast in Alzheimer's disease.

Salat DH, Chen JJ, van der Kouwe AJ, Greve DN, Fischl B, Rosas HD.

Neuroimage. 2011 Feb 1;54(3):1795-802. doi: 10.1016/j.neuroimage.2010.10.034. Epub 2010 Oct 18.

18.

Neuropathological basis of magnetic resonance images in aging and dementia.

Jagust WJ, Zheng L, Harvey DJ, Mack WJ, Vinters HV, Weiner MW, Ellis WG, Zarow C, Mungas D, Reed BR, Kramer JH, Schuff N, DeCarli C, Chui HC.

Ann Neurol. 2008 Jan;63(1):72-80.

20.

The in vivo topography of cortical changes in healthy aging and prodromal Alzheimer's disease.

Prestia A, Baglieri A, Pievani M, Bonetti M, Rasser PE, Thompson PM, Marino S, Bramanti P, Frisoni GB.

Suppl Clin Neurophysiol. 2013;62:67-80.

PMID:
24053032

Supplemental Content

Support Center